State Street Corp Supernus Pharmaceuticals, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 2,156,426 shares of SUPN stock, worth $77.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,156,426

Previous 2,163,841 0.34%

Holding current value

$77.9 Million

Previous $57.9 Million 16.16%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$25.77 - $35.16 $191,084 - $260,711	-7,415 Reduced 0.34%	2,156,426 $67.2 Million
Q2 2024 Aug 14, 2024	BUY	$25.99 - $33.85 $3.25 Million - $4.24 Million	125,195 Added 6.14%	2,163,841 $57.9 Million
Q1 2024 May 15, 2024	SELL	$27.11 - $35.17 $641,964 - $832,825	-23,680 Reduced 1.15%	2,038,646 $69.5 Million
Q4 2023 Feb 14, 2024	BUY	$22.72 - $29.68 $3.3 Million - $4.31 Million	145,316 Added 7.58%	2,062,326 $59.7 Million
Q3 2023 Nov 14, 2023	BUY	$27.57 - $32.91 $1.32 Million - $1.57 Million	47,718 Added 2.55%	1,917,010 $52.9 Million
Q2 2023 Aug 14, 2023	SELL	$29.91 - $38.73 $2.09 Million - $2.7 Million	-69,842 Reduced 3.6%	1,869,292 $56.2 Million
Q1 2023 May 15, 2023	BUY	$34.93 - $42.03 $1.88 Million - $2.26 Million	53,734 Added 2.85%	1,939,134 $70.3 Million
Q4 2022 Feb 14, 2023	SELL	$31.09 - $37.88 $1.18 Million - $1.44 Million	-37,895 Reduced 1.97%	1,885,400 $67.3 Million
Q3 2022 Nov 15, 2022	SELL	$28.79 - $35.41 $1.58 Million - $1.94 Million	-54,886 Reduced 2.77%	1,923,295 $65.1 Million
Q2 2022 Aug 15, 2022	BUY	$25.33 - $34.25 $3.4 Million - $4.59 Million	134,042 Added 7.27%	1,978,181 $57.2 Million
Q1 2022 May 16, 2022	BUY	$28.51 - $32.9 $1.75 Million - $2.02 Million	61,282 Added 3.44%	1,844,139 $59.6 Million
Q4 2021 Feb 14, 2022	SELL	$26.37 - $34.22 $1.19 Million - $1.54 Million	-44,984 Reduced 2.46%	1,782,857 $52 Million
Q3 2021 Nov 15, 2021	BUY	$23.54 - $31.39 $8,497 - $11,331	361 Added 0.02%	1,827,841 $48.7 Million
Q2 2021 Aug 16, 2021	BUY	$26.72 - $33.19 $1.33 Million - $1.65 Million	49,818 Added 2.8%	1,827,480 $56.3 Million
Q1 2021 May 17, 2021	BUY	$24.15 - $31.45 $46,198 - $60,163	1,913 Added 0.11%	1,777,662 $46.5 Million
Q4 2020 Feb 16, 2021	BUY	$17.7 - $25.81 $46,250 - $67,441	2,613 Added 0.15%	1,775,749 $44.7 Million
Q3 2020 Nov 10, 2020	SELL	$20.2 - $25.05 $1.33 Million - $1.65 Million	-65,737 Reduced 3.57%	1,773,136 $37 Million
Q2 2020 Aug 14, 2020	SELL	$17.09 - $24.89 $129,268 - $188,267	-7,564 Reduced 0.41%	1,838,873 $43.7 Million
Q1 2020 May 11, 2020	BUY	$14.45 - $24.69 $26.7 Million - $45.6 Million	1,846,437 New	1,846,437 $33.2 Million

Others Institutions Holding SUPN

# of Institutions

282

Shares Held

60.9M

Call Options Held

27.7K

Put Options Held

11.3K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.93B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Supernus Pharmaceuticals, Inc. Transaction History